Plexxikon Articles

Unprecedented survival results for B-MS Yervoy and Roche’s vemurafenib in melanoma discussed at ASCO

7 June 2011

Roche files for US and EU approval of vemurafenib for metastatic skin cancer

12 May 2011

Daiichi Sankyo broadens cancer pipeline buying Plexxikon for $805 million

1 March 2011

Plexxikon/Roche’s PLX4032 hailed as cancer's “penicillin moment”

16 September 2010

Roche and Plexxikon’s PLX4032 shows 81% response in metastatic melanoma patients in Ph I trial

26 August 2010

Melanoma cases to double, providing promising pipeline and significant opportunities for drug developers willing to invest

23 June 2010

Showing 1-6 of 6 articles

Go to beginning

Previous

1

Next

Go to end